Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy

Stefania Gori; Alessandro Inno; Lorenzo Belluomini; Paolo Bocus; Zeno Bisoffi; Antonio Russo; Guido Arcaro

doi:10.1016/j.critrevonc.2019.09.003

Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy

Stefania Gori, Alessandro Inno, Lorenzo Belluomini, Paolo Bocus, Zeno Bisoffi, Antonio Russo, Guido Arcaro

Istituto Sacro Cuore Don Calabria - Negrar

Research output: Contribution to journal › Review article › peer-review

Abstract

Gut microbiota is involved in gastrointestinal carcinogenesis. Also, it modulates the activity, efficacy and toxicity of several chemotherapy agents, such as gemcitabine, cyclophosphamide, irinotecan, cisplatin and 5-Fluorouracil, and target therapy, such as tyrosine kinase inhibitors. More recently, accumulating data suggest that the composition of gut microbiota may also affect efficacy and toxicity of cancer immunotherapy. Therefore, the manipulation of gut microbiota through antibiotics, probiotics, prebiotics or fecal transplantation has been investigating with the aim to improve efficacy and mitigate toxicity of anticancer drugs.

Original language	English
Pages (from-to)	139-147
Number of pages	9
Journal	Critical Reviews in Oncology/Hematology
Volume	143
DOIs	https://doi.org/10.1016/j.critrevonc.2019.09.003
Publication status	Published - Nov 2019

Keywords

5-Fluorouracil
Cisplatin
Cyclophosphamide
Gemcitabine
Immune checkpoint inhibitors
Irinotecan
Microbiota
Tyrosine kinase inhibitors

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1016/j.critrevonc.2019.09.003

Fingerprint Dive into the research topics of 'Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy'. Together they form a unique fingerprint.

Cite this

Gut microbiota and cancer : How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy. / Gori, Stefania; Inno, Alessandro; Belluomini, Lorenzo; Bocus, Paolo; Bisoffi, Zeno; Russo, Antonio; Arcaro, Guido.

In: Critical Reviews in Oncology/Hematology, Vol. 143, 11.2019, p. 139-147.

Research output: Contribution to journal › Review article › peer-review

@article{e35fe0123038496c8ae086393adf9d11,

title = "Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy",

abstract = "Gut microbiota is involved in gastrointestinal carcinogenesis. Also, it modulates the activity, efficacy and toxicity of several chemotherapy agents, such as gemcitabine, cyclophosphamide, irinotecan, cisplatin and 5-Fluorouracil, and target therapy, such as tyrosine kinase inhibitors. More recently, accumulating data suggest that the composition of gut microbiota may also affect efficacy and toxicity of cancer immunotherapy. Therefore, the manipulation of gut microbiota through antibiotics, probiotics, prebiotics or fecal transplantation has been investigating with the aim to improve efficacy and mitigate toxicity of anticancer drugs.",

keywords = "5-Fluorouracil, Cisplatin, Cyclophosphamide, Gemcitabine, Immune checkpoint inhibitors, Irinotecan, Microbiota, Tyrosine kinase inhibitors",

author = "Stefania Gori and Alessandro Inno and Lorenzo Belluomini and Paolo Bocus and Zeno Bisoffi and Antonio Russo and Guido Arcaro",

year = "2019",

month = nov,

doi = "10.1016/j.critrevonc.2019.09.003",

language = "English",

volume = "143",

pages = "139--147",

journal = "Critical Reviews in Oncology/Hematology",

issn = "1040-8428",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Gut microbiota and cancer

T2 - How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy

AU - Gori, Stefania

AU - Inno, Alessandro

AU - Belluomini, Lorenzo

AU - Bocus, Paolo

AU - Bisoffi, Zeno

AU - Russo, Antonio

AU - Arcaro, Guido

PY - 2019/11

Y1 - 2019/11

N2 - Gut microbiota is involved in gastrointestinal carcinogenesis. Also, it modulates the activity, efficacy and toxicity of several chemotherapy agents, such as gemcitabine, cyclophosphamide, irinotecan, cisplatin and 5-Fluorouracil, and target therapy, such as tyrosine kinase inhibitors. More recently, accumulating data suggest that the composition of gut microbiota may also affect efficacy and toxicity of cancer immunotherapy. Therefore, the manipulation of gut microbiota through antibiotics, probiotics, prebiotics or fecal transplantation has been investigating with the aim to improve efficacy and mitigate toxicity of anticancer drugs.

AB - Gut microbiota is involved in gastrointestinal carcinogenesis. Also, it modulates the activity, efficacy and toxicity of several chemotherapy agents, such as gemcitabine, cyclophosphamide, irinotecan, cisplatin and 5-Fluorouracil, and target therapy, such as tyrosine kinase inhibitors. More recently, accumulating data suggest that the composition of gut microbiota may also affect efficacy and toxicity of cancer immunotherapy. Therefore, the manipulation of gut microbiota through antibiotics, probiotics, prebiotics or fecal transplantation has been investigating with the aim to improve efficacy and mitigate toxicity of anticancer drugs.

KW - 5-Fluorouracil

KW - Cisplatin

KW - Cyclophosphamide

KW - Gemcitabine

KW - Immune checkpoint inhibitors

KW - Irinotecan

KW - Microbiota

KW - Tyrosine kinase inhibitors

UR - http://www.scopus.com/inward/record.url?scp=85073270640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073270640&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2019.09.003

DO - 10.1016/j.critrevonc.2019.09.003

M3 - Review article

C2 - 31634731

AN - SCOPUS:85073270640

VL - 143

SP - 139

EP - 147

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

ER -